The INDICAID Repid Antigen Test is a lateral flow immunoassay desgined for the qualitative detection of SARS-CoV-2 antigens in direct nasal swab samples. Authorized for self-test and professional use in Singapore by the Health Sciences Authority (HSA) under the Pandemic Special Access Route (PSAR).
Fast: Intuitive visual results in 20 minutes.
Accurate: Clinically validated with overall sensitivity and specificity at 91% and 96% respectively.
Easy-To-Use: No special equipment or facilities needed.
Variants Detectability: Able to detect the presence of certain variants.
Population Screening: For both symptom and asymptomatic individuals.